Hogan Lovells and Ropes & Gray have taken lead roles on Genzyme’s $925m (£591m) sale of its genetic testing business, Genzyme Genetics, to Laboratory Corporation of America Holdings (LabCorp), reports The Am Law Daily.

Hogan Lovells advised LabCorp, with M&A partner Michael Silver taking the lead role alongside partners John Booher, William Intner and Joseph Krauss.